BRCA1 and BRCA2: 1994 and beyond

Molecular portraits of human breast tumours

Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551

Gene expression profiling predicts clinical outcome of breast cancer

van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1

Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069

Repeated observation of breast tumor subtypes in independent gene expression data sets

Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508

Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680

Identification of the breast cancer susceptibility gene BRCA2

Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645

Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., & Sekiya, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2766 · Cited by 3,589

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463

Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21

Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Struewing, J., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,399

Evolving DNA repair synthetic lethality targets in cancer

Kulkarni, S., Brownlie, J., Jeyapalan, J. N., Mongan, N. P., Rakha, E. A., & Madhusudan, S. (2022) · Bioscience Reports · doi:10.1042/bsr20221713 · Cited by 27

K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks

Zhu, B., Yan, K., Li, L., Lin, M., Zhang, S., He, Q., Zheng, D., Yang, H., & Shao, G. (2014) · Oncogene · doi:10.1038/onc.2014.229 · Cited by 25

Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours

Milner, R. D. B., Wombwell, H., Eckersley, S., Barnes, D., Warwicker, J., Dorp, E. V., Dearden, S. P., Hughes, G., Harbron, C. G., Wellings, B., et al. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1368-y · Cited by 25

Down-regulation of UCRP and UBE2L6 in BRCA2 knocked-down human breast cells

Tripathi, M. K., & Chaudhuri, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.142 · Cited by 25

Modern cancer epidemiological research: genetic polymorphisms and environment

Filho, V. W., & Zago, M. A. (2005) · Revista de Saúde Pública · doi:10.1590/s0034-89102005000300023 · Cited by 25

Genetic Dependence and Genetic DiseasesPreprint

Li, B., Bian, W., Zhou, P., Wang, J., Fan, C.-X., Xu, H., Yu, L., He, N., Shi, Y., Su, T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.02.551736 · Cited by 25

BRCA population screening for predicting breast cancer: for or against?

Lippi, G., Mattiuzzi, C., & Montagnana, M. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.71 · Cited by 24

Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk

Serrano‐Fernández, P., Dębniak, T., Górski, B., Bogdanova, N. V., Dörk, T., Cybulski, C., Huzarski, T., Byrski, T., Gronwald, J., Wokołorczyk, D., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0249-1 · Cited by 24

Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

Amankwah, E. K., Lin, H., Tyrer, J. P., Lawrenson, K., Dennis, J., Chornokur, G., Aben, K. K. H., Anton‐Culver, H., Antonenkova, N., Bruinsma, F., et al. (2015) · Genetic Epidemiology · doi:10.1002/gepi.21921 · Cited by 24

Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study

AL-Eitan, L. N., Jamous, R. I., & Khasawneh, R. H. (2017) · Cancer Investigation · doi:10.1080/07357907.2017.1289217 · Cited by 24

Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical–pathological features in BRCA carriers and non-carriers

Barrios, X. G., Meseguer, M. D. S., Vera, M. M., Bermúdez, A. I. S., Cerrolaza, J. A. M., Henarejos, P. S., Poves, M. Z., Hernández, M. G. G., Tortosa, E. C., Baño, Á. A., et al. (2017) · Familial Cancer · doi:10.1007/s10689-017-9985-x · Cited by 21

The Biological Basis of Radiation Oncology

Zeman, E. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00001-0 · Cited by 26

Genetic testing for BRCA1 and BRCA2 in the Province of Ontario

Finch, A., Wang, M., Fine, A. D., Atri, L., Khalouei, S., Pupavac, M., Rosen, B. P., Eisen, A. F., Elser, C., Charames, G. S., et al. (2015) · Clinical Genetics · doi:10.1111/cge.12647 · Cited by 24

Abnormalities of the Inactive X Chromosome Are a Common Feature of BRCA1 Mutant and Sporadic Basal-like Breast CancerPreprint

Ganesan, S., Richardson, A. L., Wang, Z. C., Iglehart, J. D., Miron, A., Feunteun, J., Silver, D. P., & Livingston, D. M. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.045 · Cited by 24

Breast Magnetic Resonance Imaging for Screening High-Risk Women

Sung, J. S., & Dershaw, D. D. (2013) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2013.02.006 · Cited by 23

E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells

Duan, H., Mansour, S., Reed, R., Gillis, M. K., Parent, B., Liu, B., Sztupinszki, Z. M., Birkbak, N. J., Szállási, Z., Elia, A. E. H., et al. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201908192 · Cited by 22

Human BRCA pathogenic variants were originated during recent human history

Li, J., Zhao, B., Huang, T., Qin, Z., & Wang, S. M. (2022) · Life Science Alliance · doi:10.26508/lsa.202101263 · Cited by 23

A global perspective on the ethnic-specific BRCA variation and its implication in clinical application

Wang, S. M. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.12.001 · Cited by 25

Functional Interaction Between BRCA1 and DNA Repair in Yeast May Uncover a Role of RAD50, RAD51, MRE11A, and MSH6 Somatic Variants in Cancer Development

Maresca, L., Lodovichi, S., Lorenzoni, A., Cervelli, T., Monaco, R., Spugnesi, L., Tancredi, M., Falaschi, E., Zavaglia, K. M., Landucci, E., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00397 · Cited by 25

Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations

Pouptsis, A., Swafe, L., Patwardhan, M., & Stavraka, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.553080 · Cited by 23

Immunohistology of the Female Genital Tract

Rabban, J. T., Soslow, R. A., & Zaloudek, C. Z. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5766-6.00022-4 · Cited by 23

Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals

de Silva, W., Karunanayake, E., Tennekoon, K., Allen, M., Amarasinghe, I., Angunawala, P., & Ziard, M. H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-214 · Cited by 27

Structural basis to characterise transactivation domain of BRCA1

Yadav, L. R., Biswal, M. N., Hosur, M. V., Kumar, N. S., & Varma, A. K. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1136896 · Cited by 22

miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells

Crippa, E., Folini, M., Pennati, M., Zaffaroni, N., Pierotti, M. A., & Gariboldi, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7617 · Cited by 22

BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer

Kotsopoulos, J., Willows, K., Trat, S., Kim, R. H., Volenik, A., Sun, P., Narod, S. A., Boyd, J. A., & May, T. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001144 · Cited by 22

LepR+ niche cell–derived AREG compromises hematopoietic stem cell maintenance under conditions of DNA repair deficiency and aging

Wu, L., Lin, Q., Chatla, S., Amarachintha, S. P., Wilson, A. F., Atale, N., Gao, Z. J., Joseph, J., Wolff, E. V., & Du, W. (2023) · Blood · doi:10.1182/blood.2022018212 · Cited by 20

The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China

Li, Y. T., Duo, N., Yang, L., Zhao, Q., & Ou, J. H. (2014) · European journal of medical research · doi:10.1186/2047-783x-19-35 · Cited by 22

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece

Koumpis, C., Dimitrakakis, C., Antsaklis, A., Royer, R., Zhang, S., Narod, S., & Kotsopoulos, J. (2011) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-9-10 · Cited by 25

Turnover of BRCA1 Involves in Radiation-Induced Apoptosis

Liu, W., Zong, W., Wu, G. Y., Fujita, T., Li, W., Wu, J. Q., & Wan, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014484 · Cited by 24

Rate of BRCA mutation in patients tested under NCCN genetic testing criteria

Beck, A. C., Yuan, H., Liao, J., Imperiale, P., Shipley, K., Erdahl, L. M., Sugg, S. L., Weigel, R. J., & Lizarraga, I. M. (2019) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2019.06.012 · Cited by 22

Breast Cancer Stem Cells, Pathways and Therapeutic Perspectives 2011

Nigam, A. (2012) · Indian Journal of Surgery · doi:10.1007/s12262-012-0616-3 · Cited by 22

Public health in the genomic era: will Public Health Genomics contribute to major changes in the prevention of common diseases?

Cleeren, E., der Heyden, J. V., Brand, A. M., & Oyen, H. J. V. (2011) · Archives of Public Health · doi:10.1186/0778-7367-69-8 · Cited by 22

Management of Women Who Have a Genetic Predisposition for Breast Cancer

Jatoi, I., & Anderson, W. F. (2008) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.04.007 · Cited by 22

The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer

Chen, L., Fu, F., Huang, M., Lv, J., Zhang, W., & Wang, C. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05573-x · Cited by 21

A Common SNP of IL-10 (-1082A/G) is Associated With Increased Risk of Premenopausal Breast Cancer in South Indian Women

Cingeetham, V., Jyothy, A., Kumar, M. V., Raman, R. R., Nallari, P., & Ananthapur, V. (2015) · Iranian Journal of Cancer Prevention · doi:10.17795/ijcp-3434 · Cited by 21

BRCA2: breaks, mistakes and failed separations

Rudkin, T. M., & Foulkes, W. D. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.02.003 · Cited by 21

Identification and functional characterization of a PP1-binding site in BRCA1

Hsu, L. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.090 · Cited by 22

AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines.

Privat, M., Aubel, C., Arnould, S., Communal, Y., Ferrara, M., & Bignon, Y. (2010) · PubMed · Cited by 21

Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven

Wang, Y., Wiltshire, T. D., Senft, J., Wenger, S. L., Reed, E., & Wang, W. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0427 · Cited by 21

Hydrophobic Tag Tethering Degradation, The Emerging Targeted Protein Degradation Strategy

Gao, J., Zhang, J., Han, X., & Zhou, J. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220930120328 · Cited by 20

The BRCA2 c.9004G>A (E2003K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent

Cote, S., Arcand, S. L., Royer, R., Nolet, S., Mes‐Masson, A., Ghadirian, P., Foulkes, W. D., Tischkowitz, M. D., Narod, S. A., Provencher, D. M., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1796-4 · Cited by 20

Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex

Thompson, C., MacDonald, G., & Mueller, C. R. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-62 · Cited by 20

DNA Repair and Cytotoxic Drugs: the Potential Role of RAD51 in Clinical Outcome of Non-Small-Cell Lung Cancer Patients

Nogueira, A., Assis, J., Catarino, R., & Medeiros, R. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.48 · Cited by 20

Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas

Pinto, P., Peixoto, A., Santos, C., Rocha, P., Pinto, C., Pinheiro, M., Leça, L. B., Martins, A. T., Ferreira, V., Bartosch, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161438 · Cited by 22

Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancer

Yu, L., Wang, G., Zhang, Q., Gao, L., Huang, R., Chen, Y., Tang, Q., Liu, J., Liu, C., Wang, H., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.5579 · Cited by 20

Abduction Based Drug Target Discovery Using Boolean Control Network

Biane, C., & Delaplace, F. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-67471-1_4 · Cited by 21

Breast Cancer Research in the Caribbean: Analysis of Reports From 1975 to 2017

Ragin, C. C. R., Banydeen, R., Zhang, C., Ben, A., Calabrese, V., Villa, N., Reville, J., Dasgupta, S., Bandyopadhyay, M., Louden, D. M., et al. (2018) · Journal of Global Oncology · doi:10.1200/jgo.18.00044 · Cited by 20

BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients

Keshavarzi, F., Javadi, G. R., & Zeinali, S. (2011) · Familial Cancer · doi:10.1007/s10689-011-9477-3 · Cited by 20

Pharmaco(epi)Genomics in Ovarian Cancer

Paige, A. J. W., & Brown, R. E. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.12.1825 · Cited by 22

Histopathological features of breast cancer in carriers of ATM gene variants

Balleine, R. L., Murali, R., Bilous, A. M., Farshid, G., Waring, P., Provan, P. J., Byth, K., Thorne, H., kConFab Investigators, & Kirk, J. A. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02538.x · Cited by 20

A common missense variant in BRCA2 predisposes to early onset breast cancer

Górski, B., Narod, S. A., & Lubiński, J. (2005) · Breast Cancer Research · doi:10.1186/bcr1338 · Cited by 20

BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis

Feng, Z., Yang, X.-B., Tian, M., Zeng, N., Bai, Z., Deng, W., Zhao, Y., Guo, J.-H., Yang, Y.-C., Zhang, Z.-T., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11328-w · Cited by 18

Proteomics Analysis to Assess the Role of Mitochondria in BRCA1-Mediated Breast Tumorigenesis

Concolino, A., Olivo, E., Tammè, L., Fiumara, C. V., Angelis, M. T. D., Quaresima, B., Agosti, V., Costanzo, F. S., Cuda, G., & Scumaci, D. (2018) · Proteomes · doi:10.3390/proteomes6020016 · Cited by 19

Gynecological–endocrinological aspects in women carriers of BRCA1/2 gene mutations

Doren, A., Vecchiola, A., Aguirre, B., & Villaseca, P. (2018) · Climacteric · doi:10.1080/13697137.2018.1514006 · Cited by 21

Effect of BRCA1 missense variants on gene reversion in DNA double-strand break repair mutants and cell cycle-arrested cells of Saccharomyces cerevisiae

Lodovichi, S., Bellè, F., Cervelli, T., Lorenzoni, A., Maresca, L., Cozzani, C., Caligo, M. A., & Galli, A. (2019) · Mutagenesis · doi:10.1093/mutage/gez043 · Cited by 19

A contribuição dos genes BRCA na predisposição hereditária ao câncer de mama

Amendola, L. C., & Vieira, R. (2005) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2005v51n4.1927 · Cited by 19

Malfunctioning DNA Damage Response (DDR) Leads to the Degeneration of Nigro-Striatal Pathway in Mouse Brain

Kirshner, M., Galron, R., Frenkel, D., Mandelbaum, G., Shiloh, Y., Wang, Z., & Barzilai, A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9643-y · Cited by 20

Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer

Huang, F., Kushner, Y. B., Langleben, A., & Foulkes, W. D. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.90 · Cited by 19

Hereditäres Mammakarzinom

Schlehe, B., & Schmutzler, R. K. (2008) · Der Chirurg · doi:10.1007/s00104-008-1556-0 · Cited by 21

Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations

Leung, E. Y., Askarian-Amiri, M., Singleton, D. C., Ferraro‐Peyret, C., Joseph, W. R., Finlay, G. J., Broom, R. J., Kakadia, P. M., Bohlander, S. K., Marshall, E., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00425 · Cited by 18

Does family history predict the age at onset of new breast cancers in BRCA1 and BRCA2 mutation‐positive families?

Panchal, S., Bordeleau, L. J., Poll, A., Llacuachaqui, M., Shachar, O., Ainsworth, P., Armel, S. R., Eisen, A. F., Sun, P., & Narod, S. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01328.x · Cited by 18

BRCA1 expression in triple negative sporadic breast cancers.

Galizia, G., Giorgetti, G., Piccinini, G., Santinelli, A., Loretelli, C., Bianchi, F., Gagliardini, D., Carbonari, G., Pisa, E., Belvederesi, L., et al. (2010) · PubMed · Cited by 18

Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers

Yost, S. E., Ruark, E., Alexandrov, L. B., & Rahman, N. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz028 · Cited by 19

Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3′‐kinase–Akt pathway

Wang, Y., Zhang, J., Li, S., He, Y., Yang, Y., Liu, X., & Wan, X. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01568.x · Cited by 18

Ferroptosis and cancer: when iron turns against tumors

Toyokuni, S., Kong, Y., Maeda, Y. K., Lyu, Q., Ohara, Y., Sato, K., Motooka, Y., Nakamura, K., & Tanaka, H. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05982-5 · Cited by 22

Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomas

Mylona, E. E., Melissaris, S., Nomikos, A., Theohari, I., Giannopoulou, I., Tzelepis, K., & Nakopoulou, L. (2014) · Pathology - Research and Practice · doi:10.1016/j.prp.2014.05.009 · Cited by 17

Screening Magnetic Resonance Imaging Recommendations and Outcomes in Patients at High Risk for Breast Cancer

Ehsani, S., Strigel, R. M., Pettke, E. N., Wilke, L. G., Tevaarwerk, A. J., DeMartini, W. B., & Wisinski, K. B. (2015) · The Breast Journal · doi:10.1111/tbj.12396 · Cited by 17

A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients

Didraga, M., van Beers, E. H., Joosse, S. A., Brandwijk, K. I. M., Oldenburg, R. A., Wessels, L. F. A., Hogervorst, F. B. L., Ligtenberg, M. J. L., Hoogerbrugge, N., Verhoef, S., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1357-x · Cited by 19

Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials

Wilkins, J. F., Cannataro, V. L., Shuch, B., & Townsend, J. P. (2018) · Oncotarget · doi:10.18632/oncotarget.25155 · Cited by 17

Roles and responsibilities of a medical geneticist

Rubinstein, W. S. (2007) · Familial Cancer · doi:10.1007/s10689-007-9148-6 · Cited by 17

Structural Basis for the BRCA1 BRCT Interaction with the Proteins ATRIP and BAAT1

Liu, X., & Ladias, J. A. A. (2013) · Biochemistry · doi:10.1021/bi400714v · Cited by 16

Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk

Hietala, M., Olsson, H. L., & Jernström, H. (2007) · Familial Cancer · doi:10.1007/s10689-007-9178-0 · Cited by 17

Wild-Type BRCA1, but not Mutated BRCA1, Regulates the Expression of the Nuclear Form of β-Catenin

Li, H., Sekine, M., Tung, N., & Avraham, H. K. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0403 · Cited by 18

The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins

Infante, M., Duran, M., Acedo, A., Sánchez-Tapia, E. M., Díez‐Gómez, B., Barroso, A., Garcia-Gonzalez, M., Feliubadaló, L., Lasa, A., de la Hoya, M., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt272 · Cited by 17

Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients

Fragoso‐Ontiveros, V., Velázquez-Aragón, J. A., Nuñez-Martínez, P. M., Mejía-Aguayo, M. D. L. L., Vidal-Millán, S., Pedroza‐Torres, A., Sánchez-Contreras, Y., Ramírez-Otero, M. A., Muñiz-Mendoza, R., Domínguez-Ortiz, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222709 · Cited by 17

The fungus Ustilago maydis and humans share disease-related proteins that are not found in Saccharomyces cerevisiae

Münsterkötter, M., & Steinberg, G. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-473 · Cited by 17

Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome

Ouyang, Y., Salstrom, J. L., Diaz-Perez, S. V., Nahas, S., Matsuno, Y., Dawson, D. W., Teitell, M. A., Horvath, S., Riggs, A. D., Gatti, R. A., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.122 · Cited by 19

DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategies

Lee, S., Kim, J., Jeong, E., & Myung, K. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103887 · Cited by 16

BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect via the PI3K/AKT signaling pathway

Liu, X., Liu, H., Zeng, L., & Lv, Y. (2022) · PeerJ · doi:10.7717/peerj.14052 · Cited by 16

Patient-reported outcomes in bilateral prophylactic mastectomy with breast reconstruction: A narrative review

Ticha, P., & Sukop, A. (2023) · The Breast · doi:10.1016/j.breast.2023.103602 · Cited by 16

BRCA1 and BRCA1 Genes and Inherited Breast and/or Ovarian Cancer: Benefits of Genetic Testing

Somasundaram, K. (2010) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-011-0049-7 · Cited by 16

BRCA1 requirement for the fidelity of plasmid DNA double‐strand break repair in cultured breast epithelial cells

Thompson, E. G., Fares, H., & Dixon, K. (2011) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21674 · Cited by 15

Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes

Akbari, M. R., Zhang, S., Fan, I., Royer, R., Li, S., Risch, H. A., McLaughlin, J. R., Rosen, B. P., Sun, P., & Narod, S. A. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100305 · Cited by 16

MSH2 role in BRCA1-driven tumorigenesis: A preliminary study in yeast and in human tumors from BRCA1-VUS carriers

Maresca, L., Spugnesi, L., Lodovichi, S., Cozzani, C., Naccarato, A. G., Tancredi, M., Collavoli, A., Falaschi, E., Rossetti, E., Aretini, P., et al. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.09.005 · Cited by 16

Comparison of Radioimmuno and Carbon Nanotube Field-Effect Transistor Assays for Measuring Insulin-Like Growth Factor-1 in a Preclinical Model of Human Breast Cancer

Jones, L. P., Stefansson, S., Kim, M. S., & Ahn, S. N. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-36 · Cited by 16

Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort

Jarhelle, E., Stensland, H. M. F. R., Mæhle, L., & Ghelue, M. V. (2016) · Familial Cancer · doi:10.1007/s10689-016-9916-2 · Cited by 15

Coming of Age in Canada: A Study of Population-Based Genetic Testing for Breast and Ovarian Cancer

Akbari, M. R., Gojska, N. M., & Narod, S. A. (2017) · Current Oncology · doi:10.3747/co.24.3828 · Cited by 17

Fine tuning chemotherapy to match BRCA1 status

Price, M. L., & Monteiro, Á. N. A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.015 · Cited by 17

Analysis of BRCA2 loss of heterozygosity in tumor tissue using droplet digital polymerase chain reaction

Cochran, R. L., Cravero, K., Chu, D. T. W., Avigdor, B. E., Toro, P. V., Beaver, J. A., Zabransky, D. J., Wong, H. Y., Cidado, J. R., Croessmann, S., et al. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.03.013 · Cited by 15

Validation of an Efficient Screening Tool to Identify Low-Income Women at High Risk for Hereditary Breast Cancer

STEWART, S. L., Kaplan, C. P., Lee, R., Joseph, G., Karliner, L., Livaudais‐Toman, J., & Pasick, R. J. (2016) · Public Health Genomics · doi:10.1159/000452095 · Cited by 15

The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families

Fierheller, C. T., Alenezi, W. M., & Tonin, P. N. (2021) · Cancers · doi:10.3390/cancers13143406 · Cited by 16

PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway

Li, H., Wang, C., Lan, L., Wu, W., Evans, I. M., Ruiz, E. J., Yan, L., Zhou, Z., Oliveira, J. M., Reis, R. L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.719192 · Cited by 15

Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer

Kast, K., Neuhann, T., Görgens, H., Becker, K., Keller, K., Klink, B., Aust, D. E., Distler, W., Schröck, E., & Schackert, H. K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-531 · Cited by 15

Biotin-mediated epigenetic modifications: Potential defense against the carcinogenicity of benzo[a]pyrene

Xia, B., Pang, L., Zhuang, Z., & Liu, J. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.11.010 · Cited by 15

Biologic Basis of Radiation Oncology

Zeman, E. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1637-5.00001-8 · Cited by 15

Immunohistology of the Female Genital Tract

Soslow, R. A., Isacson, C., & Zaloudek, C. J. (2006) · Elsevier eBooks · doi:10.1016/b978-0-443-06652-8.50022-3 · Cited by 15

Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer

Noordermeer, S. M., Wennemers, M., Bergevoet, S. M., van der Heijden, A., Tönnissen, E., Sweep, F. C. G. J., Jansen, J. H., Span, P. N., & van der Reijden, B. A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2122-5 · Cited by 15

Treatment of Hereditary Breast Cancer

Robson, M. E. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.07.011 · Cited by 15

Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4+ T cells

Lesniewski, M. L., Haviernik, P., Weitzel, R. P., Kadereit, S., Kozik, M. M., Fanning, L. R., Yang, Y., Hegerfeldt, Y., Finney, M. R., Ratajczak, M. Z., et al. (2008) · Leukemia · doi:10.1038/leu.2008.234 · Cited by 15

Promising therapeutic options in triple-negative breast cancer.

Bilici, A. E., Arslan, Ç., & Altundağ, K. (2012) · PubMed · Cited by 14

Clinically Relevant Biology of Hereditary Breast Cancer

Foulkes, W. D. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.07.010 · Cited by 17

Editorial - A decade of discovery of BRCA1 and BRCA2: Are we turning\nthe tide against hereditary breast cancers?

Rajiv, S. (2007) · Bioline International (Bioline International)

Role of tumor-suppressor gene BRCA1 and BRCA2 mutations in breast cancer

Qin, X. (2002)

In Brief: BRCA1 and BRCA2

Foulkes, W. D., & Shuen, A. Y. (2013) · The Journal of Pathology · doi:10.1002/path.4205 · Cited by 105

Breast Cancer Gene, BRCA1 and BRCA2

Choi, D. H. (2003) · Journal of Breast Cancer · doi:10.4048/jkbcs.2003.6.2.45 · Cited by 4